Pharmafile Logo

Gower Publishing

- PMLiVE

Lilly cuts deal with UK’s Sitryx for autoimmune disease drugs

The five-year deal includes Sitryx’ two lead projects

Delivering true value: what does it mean for KAM in cancer care?

Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve

Wilmington Healthcare

- PMLiVE

Remote Working: Join the Revolution Workshop

As a nation, we are still coming to terms with our ‘new normal’, where social distancing has forced us out of the office and into our homes. For some this...

Lucid Group Communications Limited

- PMLiVE

Pharma funding and M&A in 2020

Why pharma M&A has continually bucked the trend

AstraZeneca AZ

AZ’s Imfinzi gets US OK in small cell lung cancer, challenging Tecentriq

First checkpoint inhibitor to challenge Roche's Tecentriq in this indication

- PMLiVE

Amarin shares tumble following Vascepa patent loss

Judgement invalidates six key patents on fish-oil derived med

Bayer symbol

Bayer gets EU nod for prostate cancer drug Nubeqa

Enters an increasingly competitive market

Onyx Health strengthens its top team with senior appointment

Onyx Health have recently welcomed back Alex Gandhi as Account Director to strengthen their senior management team

Onyx Health

- PMLiVE

New study identifies drugs that are safe to use in COVID-19 treatment

Researchers find no evidence for or against the use of drugs like ibuprofen

- PMLiVE

J&J says COVID-19 vaccine could be ready in early 2021

Also receives US federal backing to increase manufacturing for the shot

- PMLiVE

Merck, Bayer flesh out vericiguat heart failure data at ACC

Drug reduced rate of cardiovascular deaths and hospitalisations

- PMLiVE

Start small but think big

Exploring the potential of agility in unlocking creativity

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links